Corbus Pharmaceuticals Holdings, Inc.: operating expenses

What this measure means

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Exact concept: us-gaap:OperatingExpenses. Each value covers an annual-duration reporting interval, shown with both start and end dates. Different units remain separate; no currency conversion or interpolation is applied.

Coverage of this history

Selected reporting periods run from 2013-01-01 to 2025-12-31. The SEC response was captured on 2026-09-20.

Selected filing history

Related financial histories

• Corbus Pharmaceuticals Holdings, Inc.: total assets
• Corbus Pharmaceuticals Holdings, Inc.: total liabilities
• Corbus Pharmaceuticals Holdings, Inc.: stockholders equity
• Corbus Pharmaceuticals Holdings, Inc.: cash and cash equivalents
• Corbus Pharmaceuticals Holdings, Inc.: net income or loss
• Corbus Pharmaceuticals Holdings, Inc.: operating cash flow
• Corbus Pharmaceuticals Holdings, Inc.: capital expenditure payments
• Corbus Pharmaceuticals Holdings, Inc.: revenue
• Corbus Pharmaceuticals Holdings, Inc.: contract revenue excluding tax
• Corbus Pharmaceuticals Holdings, Inc.: financing cash flow
• Corbus Pharmaceuticals Holdings, Inc.: investing cash flow
• Corbus Pharmaceuticals Holdings, Inc.: retained earnings or deficit
• Corbus Pharmaceuticals Holdings, Inc.: basic weighted-average shares
• Corbus Pharmaceuticals Holdings, Inc.: diluted weighted-average shares
• Corbus Pharmaceuticals Holdings, Inc.: basic earnings per share
• Corbus Pharmaceuticals Holdings, Inc.: diluted earnings per share
• Corbus Pharmaceuticals Holdings, Inc.: net property, plant and equipment
• Corbus Pharmaceuticals Holdings, Inc.: share-based compensation expense
• Corbus Pharmaceuticals Holdings, Inc.: operating income or loss
• Corbus Pharmaceuticals Holdings, Inc.: current assets
• Corbus Pharmaceuticals Holdings, Inc.: interest expense
• Corbus Pharmaceuticals Holdings, Inc.: current liabilities
• Corbus Pharmaceuticals Holdings, Inc.: current accounts payable
• Corbus Pharmaceuticals Holdings, Inc.: research and development expense

Inspect the source

Entity

Corbus Pharmaceuticals Holdings, Inc. / CIK 0001595097

Captured

2026-09-20T09:24:35.285Z

SEC response SHA-256

946cd75b294f9564550986f5a835381ea0b20b9b7c1140d70659a5c384e7d54a

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Latest-filed annual-report facts per unit and reporting period at capture time. Duration facts cover 300 to 400 days. This selection can include restatements and is not a point-in-time backtest dataset. Missing concepts are omitted, never zero-filled. Values retain original units and are not currency converted. Extended concepts require compatible unit shapes and at least three reporting ends with changing values within one unit. Constant or incompatible added histories are omitted.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

• Get an API key and run your first validation
• Connect the MCP server to your coding assistant
• Inspect the ALPHAC engine on GitHub
• Read the MCP server source and integration examples

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001595097.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))